`571-272-7822
`
`
`
`
`
`Paper No. 40
`Entered: June 16, 2017
`
`UNITED STATES PATENT AND TRADEMARK OFFICE
`____________
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`____________
`
`ELEKTA, INC.,
`Petitioner,
`
`v.
`
`VARIAN MEDICAL SYSTEMS, INC.,
`Patent Owner.
`____________
`
`Case IPR2016-00476
`Patent 8,116,430 B1
`____________
`
`
`
`
`Before BRIAN J. MCNAMARA, PATRICK M. BOUCHER, and
`GARTH D. BAER, Administrative Patent Judges.
`
`BAER, Administrative Patent Judge.
`
`
`
`FINAL WRITTEN DECISION
`35 U.S.C. § 318(a) and 37 C.F.R. § 42.73
`
`
`
`IPR2016-00476
`Patent 8,116,430 B1
`
`
`
`Elekta Inc. (“Petitioner”) filed a Corrected Petition (Paper 3, “Pet.”)
`
`requesting inter partes review of claims 1–3, 6–10, and 12 of U.S. Patent
`
`No. 8,116,430 (Ex. 1001, “the ’430 patent”). Pursuant to 35 U.S.C.
`
`§ 314(a), we determined the Petition showed a reasonable likelihood that
`
`Petitioner would prevail in establishing the unpatentability of claims 1–3, 6–
`
`10, and 12, and instituted an inter partes review of those claims. Paper 12
`
`(“Inst. Dec.”). Patent Owner filed a Patent Owner Response (Paper 18, “PO
`
`Resp.”) and a Motion to Amend (Paper 20), requesting cancellation of
`
`claims 1–3, 7–10, and 12. Petitioner filed a Reply to Patent Owner’s
`
`Response. Paper 26 (“Reply”). An oral hearing was held before the Board.
`
`Paper 39.
`
`We issue this Final Written Decision pursuant to 35 U.S.C. § 318(a)
`
`and 37 C.F.R. § 42.73. In this Decision, we grant Patent Owner’s Motion to
`
`Amend and order cancellation of claims 1–3, 7–10, and 12. Petitioner’s
`
`challenge to claim 6 remains for our consideration. Having considered the
`
`record before us, we conclude Petitioner has shown by a preponderance of
`
`the evidence that claim 6 of the ’430 patent is unpatentable. See 35 U.S.C.
`
`§ 316(e).
`
`
`
`I. BACKGROUND
`
`A. RELATED PROCEEDING
`
`The parties assert the ’430 patent is the subject of a proceeding before
`
`the International Trade Commission. Pet. 1; Paper 8, 2.
`
`B. THE ’430 PATENT
`
`The ’430 patent is directed to using an imaging device for radiation
`
`therapy. Ex. 1001, 1:14–16. The Specification describes a need for
`
`
`
`2
`
`
`
`IPR2016-00476
`Patent 8,116,430 B1
`
`“identifying the precise location of the target volume immediately prior to a
`
`dose of therapeutic radiation,” and, to that end, discloses a “cone beam
`
`computed tomography radiotherapy simulator and treatment machine.” Id.
`
`at 1:24–26, 52–53.
`
`Figure 3 is reproduced, in part, below:
`
`
`
`Figure 3 depicts the ’430 patent’s clinical treatment machine. Id. at 5:16–17.
`
`The Specification describes the machine as follows:
`
`The clinical treatment machine 400 includes a rotatable gantry
`402 pivotably attached to a drive stand 403. A cone-beam CT
`radiation source 404 and a flat panel imager 406 oppose each
`other and are coupled to the rotatable gantry 402. . . .
`A treatment couch 418 is positioned adjacent to the
`gantry 402 to place the patient and the target volume within the
`range of operation for the radiation source 404 and the imager
`406.
`
`Id. at 5:25–35. The Specification describes that “[the] gantry rotates around
`
`the patient while the radiation from the cone-beam CT radiation source
`
`impinges the flat-panel imager.” Id. at 2:60–63 (reference numerals
`
`omitted). “The gantry rotates and collects image data until a computer can
`
`
`
`3
`
`
`
`IPR2016-00476
`Patent 8,116,430 B1
`
`calculate a representation of the patient and the target volume.” Id. at 2:62–
`
`64 (reference numerals omitted). Then, “a treatment plan may be generated
`
`from the collected image data . . . to apply a radiation dose to a target
`
`volume” while minimizing unwanted radiation to healthy tissue and critical
`
`structures. Id. at 2:67–3:6.
`
`C. CLAIMS
`
`
`
`Claims 1 and 6 recite as follows:
`
`1. An apparatus, comprising:
`
`logic configured to modify a treatment plan for a target volume,
`the logic comprising at least one of hardwired logic and a
`programmable computer component;
`
`a rotatable gantry;
`
`a cone-beam radiation source coupled to the rotatable gantry;
`and
`
`a flat-panel imager coupled to the rotatable gantry, wherein the
`flat-panel imager is operable to capture image projection data to
`generate cone-beam computed tomography (CT) volumetric
`image data capable of being used by the logic to modify a
`treatment plan for a target volume.
`
`6. The apparatus of claim 1, further comprising a translatable
`treatment couch coupled to the rotatable gantry via a
`communications network, wherein the translatable treatment
`couch is capable of movement in three planes plus angulation.
`
`Ex. 1001, 8:63–9:8, 9:27–30.
`
`
`
`4
`
`
`
`IPR2016-00476
`Patent 8,116,430 B1
`
`
`D. INSTITUTED GROUNDS OF UNPATENTABILITY
`
`We instituted inter partes review on the following grounds of
`
`unpatentability.
`
`Reference(s)
`
`Basis
`
`Challenged Claims
`
`Jaffray MICCAI 20011
`
`§§ 102(a), (b)
`
`1, 6–10, 12
`
`Jaffray MICCAI 2001
`
`Jaffray MICCAI 2001 and
`Jaffray June 20002
`
`§ 103(a)
`
`§ 103(a)
`
`Jaffray MICCAI 2001 and
`Jaffray JRO 19993
`
`§ 103(a)
`
`1, 6–10, 12
`
`2, 3
`
`7, 8
`
`Jaffray Publication4
`
`§§ 102(b), 103(a) 1–3, 6–10, 12
`
`Inst. Dec. 21–22.
`
`II. MOTION TO AMEND
`
`Patent Owner filed a Motion to Amend, requesting cancellation of
`
`claims 1–3, 7–10, and 12, without proposing any substitute claims. Paper
`
`18, 1. Petitioner did not file an opposition to the Motion. We grant the
`
`unopposed Motion, and, accordingly, do not address further claims 1–3, 7–
`
`
`1 Jaffray et al., Image Guided Radiotherapy of the Prostate,
`MICCAI 2001, LNCS 2208 1075–80 (2001) (Ex. 1021, “Jaffray MICCAI
`2001”).
`2 Jaffray et al., Cone-Beam Computer Tomography with a Flat-Panel
`Imager: Initial Performance Characterization, 27 Medical Physics 1311–23
`(2000) (Ex. 1009, “Jaffray June 2000”).
`3 Jaffray et al., A Radiographic and Tomographic Imaging System Integrated
`into a Medical Linear Accelerator for Localization of Bone and Soft-Tissue
`Targets, 45 INT. J. RADIATION ONCOLOGY BIOL. PHYS. 773–789 (1999)
`(Ex. 1007, “Jaffray JRO 1999”).
`4 International Publication No. WO 01/60236 A2 (Pub. Aug. 23, 2001)
`(Ex. 1025, “Jaffray Publication”).
`
`
`
`5
`
`
`
`IPR2016-00476
`Patent 8,116,430 B1
`
`10, or 12. Below, we address only the instituted grounds for claim 6, the
`
`only uncanceled claim remaining in this inter partes review.
`
`III. ANALYSIS
`
`A. PRINCIPLES OF LAW
`
`Petitioner bears the burden of proving unpatentability of the
`
`challenged claims, and the burden of persuasion never shifts to Patent
`
`Owner. Dynamic Drinkware, LLC v. Nat’l Graphics, Inc., 800 F.3d 1375,
`
`1378 (Fed. Cir. 2015). To prevail, Petitioner must establish the facts
`
`supporting its challenge by a preponderance of the evidence. 35 U.S.C. §
`
`316(e); 37 C.F.R. § 42.1(d).
`
`To anticipate under 35 U.S.C. § 102, a prior art reference must
`
`disclose every limitation of the claimed invention, either explicitly or
`
`inherently. In re Schreiber, 128 F.3d 1473, 1477 (Fed. Cir. 1997). A patent
`
`claim is unpatentable under 35 U.S.C. § 103(a) if the differences between
`
`the subject matter sought to be patented and the prior art are such that the
`
`subject matter as a whole would have been obvious to a person of ordinary
`
`skill in the art at the time the invention was made. KSR Int’l Co. v. Teleflex
`
`Inc., 550 U.S. 398, 406 (2007). Obviousness is resolved based on
`
`underlying factual determinations, including: (1) the scope and content of
`
`the prior art; (2) any differences between the claimed subject matter and the
`
`prior art; (3) the level of ordinary skill in the art; and (4) objective evidence
`
`of nonobviousness, i.e., secondary considerations. See Graham v. John
`
`Deere Co., 383 U.S. 1, 17–18 (1966).
`
`
`
`6
`
`
`
`IPR2016-00476
`Patent 8,116,430 B1
`
`
`1. Applicable Standard
`
`B. CLAIM CONSTRUCTION
`
`The Board interprets claims using the “broadest reasonable
`
`construction in light of the specification of the patent in which [they]
`
`appear[].” 37 C.F.R. § 42.100(b). We presume a claim term carries its
`
`“ordinary and customary meaning,” which is “the meaning that the term
`
`would have to a person of ordinary skill in the art in question” at the time of
`
`the invention. In re Translogic Tech., Inc., 504 F.3d 1249, 1257 (Fed. Cir.
`
`2007). We construe only those claim terms necessary to resolve the
`
`controversy. See Vivid Techs., Inc. v. Am. Sci. & Eng’g, Inc., 200 F.3d 795,
`
`803 (Fed. Cir. 1999).
`
`2. “communications network”
`
`Patent Owner asserts “[a] communications network is ‘a
`
`communication system that facilitates communication between many
`
`devices and that uses a networking protocol to selectively route messages to
`
`their intended devices’.” PO Resp. 8. In Reply, Petitioner proposes a
`
`broader construction: “a link between two or more components of the
`
`radiation treatment system that allows information to be shared between
`
`them.” Reply 5.
`
`In our Final Written Decision in Elekta, Inc. v. Varian Medical
`
`Systems, Inc., IPR2015-01401, Paper 56 (“IPR2015-01401 FWD”), we
`
`construed the same term based on nearly identical arguments and
`
`substantially the same evidence. See IPR2015-01401 FWD 7–8. In our
`
`Decision, we rejected the same argument Patent Owner presents in this
`
`case—that a “communications network” requires a networking protocol to
`
`selectively route messages to their intended devices. See id. We did so
`
`
`
`7
`
`
`
`IPR2016-00476
`Patent 8,116,430 B1
`
`because neither the term’s plain language nor the specification5 supported
`
`imposing such a requirement. See id. For the same reasons explained in
`
`IPR2015-01401, we maintain our agreement with Petitioner—under the
`
`broadest reasonable construction, a communications network is simply a link
`
`between two or more components of the radiation treatment system that
`
`allows information to be shared between them.
`
`1. Jaffray MICCAI 2001 (Ex. 1021)
`
`C. ASSERTED PRIOR ART
`
`Jaffray MICCAI 2001 is a nonpatent article titled “Image Guided
`
`Radiotherapy of the Prostate.” Ex. 1021, 1075. Jaffray MICCAI 2001
`
`published in October 2001 in the journal Lecture Notes in Computer Science
`
`and is prior art under pre-AIA 35 U.S.C. §§ 102(a) and (b). Pet. 11. Jaffray
`
`MICCAI 2001’s Figure 1(a) is reproduced below.
`
`
`
`
`5 IPR2015-01401 addressed related U.S. Patent No. 7,945,021 (“the ’021
`patent”). The ’430 patent at issue in this case is a continuation of application
`No. 10/324,227, which issued as the ’021 patent.
`
`
`
`8
`
`
`
`IPR2016-00476
`Patent 8,116,430 B1
`
`
`
`
`
`
`Figure 1(a) depicts a “[p]rototype cone beam CT scanner mounted on the
`
`gantry of a commercial medical linear accelerator,” including “[a] diagnostic
`
`X-ray tube (right) and a flat panel imager (left) [that] have been added.” Id.
`
`at 1076. Under “Material and Methods,” Jaffray MICCAI 2001 describes
`
`the following:
`
`A cone beam CT scan will be acquired on the treatment
`machine for each treatment fraction (Fig. 1). This 3D CT data
`set is analyzed automatically to localize the prostate and the
`treatment prescription is adapted to match the actual position
`and orientation of the prostate. Finally, the treatment is
`delivered.
`
`Id.
`
`2. The Jaffray Publication (Ex. 1025)
`
`The Jaffray Publication is International Publication No.
`
`WO 01/60236, published August 23, 2001, and is prior art under pre-AIA
`
`
`
`9
`
`
`
`IPR2016-00476
`Patent 8,116,430 B1
`
`35 U.S.C. § 102(b). Ex. 1025, Elekta_000002363; Pet. 14. The reference is
`
`titled “Cone Beam Comput[ed] Tomography with a Flat Panel Imager” and
`
`discloses “[a] radiation therapy system that includes a radiation source that
`
`moves about a path and directs a beam of radiation towards an object and a
`
`cone-beam computer tomography system.” Ex. 1025, Elekta_000002363.
`
`The reference describes the system also includes “an x-ray source that emits
`
`an x-ray beam in a cone-beam form towards an object to be imaged” and “an
`
`amorphous silicon flat-panel imager . . . [for] providing an image of the
`
`object.” Id. at Elekta_000002363.
`
`D. INSTITUTED GROUNDS OF UNPATENTABILITY
`
`1. Anticipation of Claim 6 Based on Jaffray MICCAI 2001
`
`Petitioner contends Jaffray MICCAI 2001 anticipates claim 6. Pet.
`
`15–16, 19–24. Based on our review of the arguments and evidence in the
`
`Petition, Response, and Reply, we determine Petitioner has demonstrated, by
`
`a preponderance of the evidence, Jaffray MICCAI 2001 anticipates claim 6,
`
`as explained below.
`
`a. Disputed Limitation
`
`i. Jaffray MICCAI 2001 Teaches “a translatable treatment couch
`coupled to the rotatable gantry via a communications network”
`
`Claim 6 requires “a translatable treatment couch coupled to the
`
`rotatable gantry via a communications network.” As Petitioner explains, the
`
`linear accelerator in Jaffray MICCAI 2001 is an Elekta SL-20. Pet. 16
`
`(citing Ex. 1021, 1076; Ex. 1026 ¶ 167), 24 (citing Ex. 1021, 1076, Fig. 1;
`
`Ex. 1026 ¶¶ 156, 167). A technical note describing the SL-20 explains as
`
`follows: “The hardware/software interaction of the SL-20 makes it
`
`particularly suitable for automated data collection. Communication between
`
`the control processor and the accelerator, gantry and patient couch is
`
`
`
`10
`
`
`
`IPR2016-00476
`Patent 8,116,430 B1
`
`handled by a pair of high-speed serial links. These are daisy-chained
`
`through three separate control areas distributed throughout the machine.”
`
`Ex. 1015, 220. “[R]ecourse to extrinsic evidence is proper to determine
`
`whether a feature, while not explicitly discussed, is necessarily present in a
`
`reference.” Telemac Cellular Corp. v. Topp Telecom, Inc., 247 F.3d 1316,
`
`1328 (Fed. Cir. 2001). In light of Exhibit 1015, we agree with Petitioner one
`
`skilled in the art would understand Jaffray MICCAI 2001’s translatable
`
`treatment couch and rotatable gantry are coupled via a communications
`
`network—i.e., a link between the two components that allows information to
`
`be shared between them. See Pet. 24 (citing Ex. 1021, 1076, Fig. 1;
`
`Ex. 1015, 220; Ex. 1026 ¶¶ 156, 167); see also Reply 7–12; Ex. 1031 ¶¶ 19–
`
`29.
`
`Patent Owner does not dispute one skilled in the art would recognize
`
`Jaffray MICCAI 2001 employs an Elekta SL-20 that has a treatment couch
`
`and rotatable gantry that communicate via high-speed serial links. See PO
`
`Resp. 27–28; Ex. 2003 ¶¶ 87–89. Instead, Patent Owner relies on its
`
`proffered construction of communications network, and asserts Jaffray
`
`MICCAI 2001 is deficient because “[h]igh speed serial links alone do not
`
`route messages using network protocols.” PO Resp. 27. We find Patent
`
`Owner’s argument unpersuasive because, as explained above, we do not
`
`construe a communications network to require a networking protocol or
`
`selectively routing messages. Thus, we find one skilled in the art would
`
`understand Jaffray MICCAI 2001 includes a translatable treatment couch
`
`coupled to the rotatable gantry via a communications network, as claim 6
`
`requires.
`
`
`
`11
`
`
`
`IPR2016-00476
`Patent 8,116,430 B1
`
`
`b. Unchallenged Limitations
`
`Petitioner contends Jaffray MICCAI 2001 discloses the remaining,
`
`unchallenged limitations of claim 6. See Pet. 15–16; 19–24. Patent Owner
`
`does not address the merits of Petitioner’s assertions regarding the remaining
`
`limitations. See PO Resp. 21–28. We agree with Petitioner’s assertions, as
`
`outlined below.
`
`Petitioner has shown Jaffray MICCAI 2001 discloses “An apparatus,
`
`comprising: logic configured to modify a treatment plan for a target volume,
`
`the logic comprising at least one of hardwired logic and a programmable
`
`computer component,” as claim 6 requires. See Pet. 15–16, 19–22 (citing
`
`Ex. 1021, Abstract, 1076–78, Fig. 1; Ex. 1026 ¶¶ 154, 159–163). Petitioner
`
`has shown Jaffray MICCAI 2001 discloses also “a rotatable gantry” and a
`
`cone-beam radiation source coupled to the rotatable gantry.” See id. at 15–
`
`16, 22 (citing Ex. 1021, 1076, Fig. 1; Ex. 1026 ¶¶ 155, 156). Petitioner has
`
`shown Jaffray MICCAI 2001 discloses “a flat-panel imager coupled to the
`
`rotatable gantry, wherein the flat-panel imager is operable to capture image
`
`projection data to generate cone-beam computed tomography (CT)
`
`volumetric image data capable of being used by the logic to modify a
`
`treatment plan for a target volume.” See id. at 15–16, 22–24 (citing
`
`Ex. 1021, Abstract, 1076, 1077, Fig. 1; Ex. 1026 ¶¶ 156, 160–162). In
`
`addition, Petitioner has shown Jaffray MICCAI 2001 discloses a translatable
`
`treatment couch that “is capable of movement in three planes plus
`
`angulation.” See id. at 24 (citing Ex. 1021, 1076, Fig. 1; Ex. 1026 ¶¶ 156,
`
`167).
`
`
`
`12
`
`
`
`IPR2016-00476
`Patent 8,116,430 B1
`
`
`c. Conclusion
`
`For these reasons, having considered the parties’ contentions and
`
`supporting evidence, we determine Petitioner has demonstrated, by a
`
`preponderance of the evidence, claim 6 is unpatentable under 35 U.S.C.
`
`§§ 102(a) and (b) over Jaffray MICCAI 2001.
`
`2. Obviousness of Claim 6 Based on Jaffray MICCAI 2001
`
`Petitioner asserts “to the extent [claim 6 is] not found to be anticipated
`
`by Jaffray MICCAI 2001, [claim 6] would have been obvious in view of
`
`Jaffray MICCAI 2001.” Pet. 27. In light of our findings on anticipation
`
`based on Jaffray MICCAI 2001, and absent any assertions of secondary
`
`considerations supporting non-obviousness, we are persuaded Petitioner has
`
`demonstrated by a preponderance of the evidence that the subject matter of
`
`claim 6 would have been obvious over Jaffray MICCAI 2001. See In re
`
`McDaniel, 293 F.3d 1379, 1385 (Fed. Cir. 2002) (“It is well settled that
`
`anticipation is the epitome of obviousness.”); cf. Cohesive Techs., Inc. v.
`
`Waters Corp., 543 F.3d 1351, 1364 (Fed. Cir. 2008) (distinguishing
`
`anticipation from obviousness because “obviousness requires analysis of
`
`secondary considerations of nonobviousness, while secondary considerations
`
`are not an element of a claim of anticipation”).
`
`3. Anticipation of Claim 6 Based on the Jaffray Publication
`
`Petitioner contends the Jaffray Publication anticipates claim 6. Pet.
`
`41–43, 44–45, 47–52, 53. Based on our review of the arguments and
`
`evidence in the Petition, Response, and Reply, we determine Petitioner has
`
`not demonstrated, by a preponderance of the evidence, the Jaffray
`
`Publication anticipates claim 6, as explained below.
`
`
`
`13
`
`
`
`IPR2016-00476
`Patent 8,116,430 B1
`
`
`a. The Jaffray Publication Does Not Teach “a translatable treatment
`couch coupled to the rotatable gantry via a communications network”
`
`Claim 6 requires “a translatable treatment couch coupled to the
`
`rotatable gantry via a communications network.” Petitioner argues the
`
`Jaffray Publication necessarily discloses this feature because it teaches “the
`
`use of a ‘computer controlled treatment table 443 for correction of lesion
`
`localization errors.’” Pet. 44 (quoting Ex. 1025, 42:5–6). In addition,
`
`according to Petitioner’s expert, Dr. Hamilton, one skilled in the art would
`
`understand the Jaffray Publication discloses this feature because it was
`
`“standard for computer systems . . . to exchange data via a communications
`
`network with linear accelerators to monitor and record the couch and gantry
`
`positions to ensure that their positions matched the treatment plan by
`
`interlocking (preventing) radiation beam delivery if they did not match.”
`
`Ex. 1026 ¶ 260.
`
`We agree with Patent Owner that using a computer-controlled
`
`treatment couch does not necessarily mean the treatment couch is connected
`
`to the gantry via a communications network, as claim 6 requires. See PO
`
`Resp. 28. As Patent Owner explains, controlling the couch with a computer
`
`“says nothing about how, if at all, the table would be coupled to the rotatable
`
`gantry.” Id. In addition, Petitioner’s standard-feature argument, even if
`
`correct, is not enough to show the Jaffray Publication necessarily discloses
`
`the disputed communications network feature. See Rexnord Indus., LLC v.
`
`Kappos, 705 F.3d 1347, 1355 (Fed. Cir. 2013) (explaining that “anticipation
`
`by inherent disclosure is appropriate only when the reference discloses prior
`
`art that must necessarily include the unstated limitation”). Thus, we find
`
`Petitioner has not shown the Jaffray Publication expressly or inherently
`
`discloses “a translatable treatment couch coupled to the rotatable gantry via
`
`
`
`14
`
`
`
`IPR2016-00476
`Patent 8,116,430 B1
`
`a communications network,” as claim 6 requires, and consequently has not
`
`met its burden to show the Jaffray Publication anticipates claim 6.
`
`4. Obviousness of Claim 6 Based on the Jaffray Publication
`
`Petitioner asserts that even if the Jaffray Publication does not
`
`anticipate claim 6, claim 6 would have been obvious over the Jaffray
`
`Publication. Pet. 58. Although Petitioner argues several claim features
`
`would have been obvious, Petitioner does not include claim 6’s limitation
`
`requiring a “translatable treatment couch coupled to the rotatable gantry via
`
`a communications network,” in the Petition’s obviousness analysis. See Pet.
`
`58–60. Thus, like its anticipation challenge based on the Jaffray Publication,
`
`Petitioner’s obviousness challenge relies on the Jaffray Publication for
`
`teaching the disputed communications-network element. As a result,
`
`Petitioner’s failure to show the Jaffray Publication teaches “a translatable
`
`treatment couch coupled to the rotatable gantry via a communications
`
`network” is fatal to its obviousness challenge to claim 6. See Par Pharm.,
`
`Inc. v. Twi Pharm., Inc., 773 F.3d 1186, 1194 (Fed. Cir. 2014) (noting that a
`
`party alleging obviousness has a “burden to prove that all claimed
`
`limitations are disclosed in the prior art”).
`
`We note that in Reply, Petitioner makes an alternative argument that
`
`even if the Jaffray Publication does not disclose the claimed
`
`communications network, including one would have been obvious to a
`
`skilled artisan. See Reply 17 (asserting that “even assuming that the
`
`disclosed computer control system of the Jaffray Publication does not
`
`anticipate the claimed communications network, it renders that network
`
`obvious by connecting the gantry, couch, and other system components to a
`
`single control computer”). We decline to reach this argument, however,
`
`
`
`15
`
`
`
`IPR2016-00476
`Patent 8,116,430 B1
`
`because Petitioner raised it for the first time in its Reply. See 37 C.F.R. §
`
`42.104(b)(5) (requiring that a petition must identify “[t]he supporting
`
`evidence relied upon to support the challenge and the relevance of the
`
`evidence to the challenge raised, including identifying specific portions of
`
`the evidence that support the challenge” and explaining that “[t]he Board
`
`may exclude or give no weight to the evidence where a party has failed to
`
`state its relevance or to identify specific portions of the evidence that support
`
`the challenge”).
`
`IV. CONCLUSION
`
`Based on our review of the arguments and evidence in the Petition,
`
`Response, and Reply, we determine Petitioner has shown, by a
`
`preponderance of the evidence, claim 6 is unpatentable under 35 U.S.C.
`
`§§ 102(a), 102(b), and 103(a) over Jaffray MICCAI 2001. Petitioner,
`
`however, has not shown claim 6 is unpatentable under 35 U.S.C. § 102(b) or
`
`§ 103(a) over the Jaffray Publication.
`
`V. PETITIONER’S CHALLENGE TO PATENT OWNER’S
`DECLARANT
`
`Petitioner argues we should give no weight to Dr. Mutic’s testimony
`
`in light of Dr. Mutic’s “long professional history with Patent Owner,
`
`involving substantial monetary compensation.” Reply 19. According to
`
`Petitioner, “Dr. Mutic’s prior, and likely future, compensation from Patent
`
`Owner renders his expert testimony biased and questionable.” Id. at 19–20.
`
`We see nothing wrong or unusual with Patent Owner compensating
`
`Dr. Mutic for work in this case, or in future ones. In assessing the merits of
`
`this case, we have considered the proffered testimony from Dr. Mutic, as
`
`well as Petitioner’s Declarant Dr. Hamilton, and accorded weight based on
`
`
`
`16
`
`
`
`IPR2016-00476
`Patent 8,116,430 B1
`
`the testimony’s substantive persuasiveness. We see no reason why Dr.
`
`Mutic’s past compensation—or his speculative future compensation—makes
`
`his testimony unhelpful in understanding the evidence. See Fed. R. Evid.
`
`702(a).
`
`In consideration of the foregoing, it is hereby:
`
`VI. ORDER
`
`ORDERED that Petitioner has shown by a preponderance of the
`
`evidence that claim 6 of the ’430 patent is unpatentable;
`
`FURTHER ORDERED that Patent Owner’s Motion to Amend (Paper
`
`20) is granted;
`
`FURTHER ORDERED that claims 1–3, 7–10, and 12 of the ’430
`
`patent shall be canceled; and
`
`FURTHER ORDERED that, because this is a Final Written Decision,
`
`the parties to the proceeding seeking judicial review of the decision must
`
`comply with the notice and service requirements of 37 C.F.R. § 90.2.
`
`17
`
`
`
`
`
`
`
`18
`
`IPR2016-00476
`Patent 8,116,430 B1
`
`
`PETITIONER:
`
`Theresa Gillis
`tgillis@mayerbrown.com
`
`Amanda Streff
`astreff@mayerbrown.com
`
`Erick Palmer
`ejpalmer@mayerbrown.com
`
`
`
`PATENT OWNER:
`
`Heidi Keefe
`hkeefe@cooley.com
`
`Daniel Knauss
`dknauss@cooley.com
`
`Scott Cole
`Varian_PTAB_IPR@cooley.com
`
`Reuben Chen
`rchen@coooley.com
`
`
`
`
`
`